1 It has been proposed that the vagus nerve plays a role in mediating cholecystokinin-8 (CCK-8) eect on such gastric functions as motility, emptying and gastric acid secretion. To examine the contribution of the eerent pathways in realizing these eects, eerent mass activity in the ventral gastric vagal nerve in Sprague-Dawley rats was recorded. 6 The results suggest that the eect of systemically administered CCK-8 on vagal eerent activity is mediated by both peripherally (subdiaphragmatically) and centrally localized CCK A receptors.
Introduction
Neuropeptide cholecystokinin-8 (CCK-8) which is released into the circulation during feeding (Lewis & Williams, 1990) has been shown to excite vagal gastric, hepatic as well as intestinal aerents (Cox & Randich, 1997; Kurosawa et al., 1997; Richards et al., 1996; Schwartz et al., 1994) . Excitation of the vagal aerent nerve conveys satiation signals to the brain (Mayne et al., 1998) , resulting in the inhibition of the food intake. At the same time the vagal aerent excitation in response to CCK-8 contributes to the re¯ex regulation of pancreatic secretion (Li et al., 1997) , gastric motility and emptying (Raybould & TacheÂ , 1988) as well as gastric acid secretion (Raybould & Lloyd, 1994) . The vagal eerent nerve is suggested to be one of the major eerent limbs of this re¯ex regulation. However, there has been no study addressing the responses of the vagal eerent activity in response to CCK-8.
The eect of CCK-8 is mediated via CCK A and CCK B receptors. In general, CCK A receptors are abundant in the gastrointestinal tract while CCK B receptors are found dominantly in the brain. However, both CCK A and CCK B receptors are described on the vagal nerves (Mercer & Lawrence, 1992) , the nucleus tractus solitarius (NTS) where vagal aerents terminate, and the dorsal motor nucleus of the vagal nerve (DMX) where vagal eerents emerge (PlataSalamaÂ n et al., 1988) . Although it has been shown that the gastric vagal aerent ®bres are activated via the CCK A receptors in response to exogenously administered CCK-8 (Kurosawa et al., 1997; Schwartz et al., 1994) , the response of the gastric vagal eerents might include the activation of both CCK A and CCK B receptors at brain stem level, including DMX and NTS (Branchereau et al., 1993) .
In the present study the response of gastric vagal eerent ®bres to exogenously administered CCK-8 and the mechanisms involved have been investigated. First, the activity of vagal eerents was recorded under conditions of partial or total subdiaphragmatic vagotomy to elucidate the extent of the contribution of subdiaphragmatic vagal aerents to the response. Second, the site of action of CCK-8 and its receptor mechanisms were investigated in animals with partial or total subdiaphragmatic vagotomy in order to explore mechanisms additional to those of the vagal aerent-mediated. Finally, the response of supradiaphragmatic vagal aerent activity to intravenous CCK-8 was investigated.
Methods

Animals
Male Sprague-Dawley rats (ALAB Sollentuna, Sweden) 350+70 g, were housed ®ve per cage at 218C, with water and food ad libitum and a 12 h light/dark cycle. Animals were deprived of food for 14 ± 20 h before the experiment. Experiments were approved by the Karolinska Institutet local animal ethical committee. 
Experimental procedures
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) were injected through the right jugular vein using a syringe pump (model STC-521, Terumo, Tokyo, Japan). Experimental substances were injected through the right femoral vein (i.v.) or into the cisterna magna (i.c.m.). For the i.c.m. injections, the dura mater covering the foramen magnum was exposed. A small hole was made with a 25 gauge needle at the midline below the caudal edge of the occipital bone and 0.4 ± 0.6 cm of polyethylene tube (PE 10, I.D. 0.28 mm, O.D. 0.61 mm; dead space 5 ml) ®lled with saline was inserted. To ensure the stable position of the catheter, a drop of Swebond (acrylic dental material, Svedia Dental-Industri AB, Sweden) was used. Free-leaking of clear CSF was considered as being proof of successful catheterization. The catheter was connected to an Exmire microsyringe (10 ml) using a silicone tube.
The abdomen was opened by midline section and the gastric branch of the ventral subdiaphragmatic vagal nerve was identi®ed on the oesophagus, separated from the surrounding tissues under a binocular microscope and cut just proximal from the entrance into the stomach. The dorsal subdiaphragmatic vagus was left intact (n=8) or cut beneath the diaphragm (n=8). All branches of the ventral subdiaphragmatic vagal nerve including the hepatic, intestinal and accessory coeliac branches were cut in all animals ( Figure 1 ). The central cut segment of the ventral gastric branch was placed on a bipolar platinum wire electrode and immersed in paran oil. The mass eerent activity was ampli®ed (ampli®cation gain 10 mV, bandpass 150 ± 1000 Hz, time constant 0.01 s) (MEG-1200, Nihon-Kohden, Japan), counted every 2 s by a pulse counter after passing through a window discriminator (MET-1100, Nihon-Kohden, Japan) and recorded on a polygraph (WS-682G, Nihon-Kohden, Japan). The lower level of the window discriminator was always set clearly above the maximal noise peak level.
The supradiaphragmatic aerent activity was recorded from the distal cut segment of a ®lament dissected from a bundle of the left cervical vagal nerve (n=8) in animals with total subdiaphragmatic vagotomy.
Sulphated cholecystokinin octapeptide (CCK-8) were ®rst dissolved in saline containing 0.1% bovine serum albumine (BSA) and diluted with saline. Then it was administered intravenously as bolus injections in doses of 0.01, 0.1 or 1 nmol (ca 0.35 ± 3.5 mg kg 71 ) in 0.2 ml saline given over 20 s. L-364,718, a CCK A receptor antagonist, and L-365,260, a CCK B receptor antagonist, were dissolved in 50% dimethyl sulfoxide (DMSO) at a concentration of 12.5 mmol ml 71 , and then diluted with saline. Antagonists were injected intravenously as bolus injections in doses of 1, 10 and 100 mg in 0.2 ml saline 5 min before the administration of CCK-8 (0.1 nmol) (n=8). In six rats 1 mg L-364,718 in 6 ml saline was injected i.c.m. and CCK-8 (0.1 nmol) subsequently injected i.v. every 10 min over a 1 h period.
Drugs
The following drugs were used: pentobarbital sodium (Apoteksbolaget, Sweden); Ficoll 70 (Pharmacia Fine Chemicals AB, Uppsala, Sweden); gallamine triethiodide, cholecystokinin-8 (CCK 26 ± 33), dimethyl sulfoxide (DMSO) and bovine serum albumine (BSA) from Sigma Chemical Co., St. Louis, MO, U.S.A.; paran oil (Kebo Lab.); L-364,718 (devazepide, or MK-329) and L-365,260 from ML Lab, London, U.K.
Statistical analysis
Responses of vagal gastric eerent activity were measured over 10 s immediately before the onset of CCK-8 administration and expressed as 100% control value. This was then compared with the average count over 10 s in every 30 s (start of the injection taken as time point zero), expressed as mean+ s.e.mean. Data were analysed by two-way repeated-measures ANOVA. When a signi®cant treatment eect was found, Dunnett's test for each group and time point was performed. Comparisons of latencies of the response were made by Student's t-test, two-tailed. Probability less than 5% was considered signi®cant.
Results
Eect of exogenous i.v. CCK-8 on vagal eerent activity in animals with partial subdiaphragmatic vagotomy
The eerent activity of the gastric vagal nerve was recorded from a branch of the central cut segment of the sectioned whole ventral subdiaphragmatic vagal nerve, i.e. the ipsilateral subdiaphragmatic vagal aerent activity was disrupted.
As shown in Figure 2 , 0.1 and 1 nmol doses of CCK-8 produced a rapid, signi®cant dose-dependent decrease in the mass activity of the gastric vagal eerent nerve (treatment 6 time interaction F(3, 33)=11.2, P50.001). Administration of 0.1 nmol of CCK-8 decreased the nerve activity to 33+5% and 52+6% of the pre-administration control at 30 and 60 s, respectively. The activity returned to its basal level 2.5 min after the administration. Injection of 1.0 nmol CCK-8 further decreased the nerve activity to 28+6% and 27+6% of pre- Intravenous injection of L-364,718, a CCK A receptor antagonist in dose of 1 mg, 5 min prior to the injection of 0.1 nmol CCK-8 partially blocked the response of vagal eerent activity in comparison to that of CCK-8 injected after saline ( Figure 3A ). Larger doses of the antagonist (10 and 100 mg) completely blocked the response (treatment 6 time interaction F(3,33)=11.5, P50.001).
Administration of L-365,260, a CCK B receptor antagonist, in the doses of 1 mg, 10 mg or 100 mg ( Figure 3B ) had no eect on the response of vagal eerent activity to 0.1 nmol CCK-8 (treatment 6 time interaction F(3,33)=0.24, P=1.0).
Eect of exogenous i.v. CCK-8 on vagal eerent activity in animals with total subdiaphragmatic vagotomy To determine the contribution of subdiaphragmatic vagal aerent activity to the responses of the vagal eerent nerve, shown in Figure 2 , the contralateral (dorsal) subdiaphragmatic vagal nerve was additionally cut. When injected 0.5 h after total vagotomy, 0.1 and 1 nmol doses of CCK-8 still produced a signi®cant dose-dependent decrease in the gastric vagal eerent nerve activity (Figure 4 ) (treatment 6 time interaction F(3,21)=5.6, P50.001), although the decrease in nerve activity was smaller than in the conditions where the subdiaphragmatic vagal aerent nerve was left intact. With 0.1 nmol CCK-8 the activity decreased to 82+6% of preadministration control after 30 s and to 81+5% after 60 s, and with 1 nmol CCK-8 to 56+2% after 30 s and to 59+4% and 60 s. The activity returned to its pre-administration level 2 min after the administration of 0.1 nmol CCK-8 and 3.5 min after 1 nmol CCK-8. The mean latency of the response to CCK-8 was signi®cantly prolonged (1 nmol CCK, 16.7+1.1 s, P50.01) after the cutting of the dorsal subdiaphragmatic vagal nerve. Neither saline nor 0.01 nmol CCK-8 aected vagal eerent nerve activity (Figure 4) .
Eect of exogenous i.v. CCK-8 on vagal eerent activity in animals with total subdiaphragmatic vagotomy after i.v. pretreatment with either CCK A or CCK B receptor antagonist
To study the contribution of the CCK receptors to the response of vagal eerent activity in rats with total subdiaphragmatic vagotomy, CCK A or CCK B receptor antagonist was administered prior to injection of 0.1 nmol CCK-8.
Intravenous injection of L-364,718, a CCK A receptor antagonist in dose of 1 mg, 5 min prior to the injection of 0.1 nmol CCK-8 partially blocked the response of vagal CCK-8 and vagal efferent activity 1651 V. Bucinskaite et al eerent activity in comparison to that of CCK-8 injected after saline ( Figure 5A ). Larger doses of the antagonist (10 and 100 mg) completely blocked the response (treatment 6 time interaction F(3,21)=3.9, P50.001).
However, the eects of 0.1 nmol CCK-8 were not attenuated by the prior administration of L-365,260, a CCK B antagonist, in the doses of 1, 10 or 100 mg ( Figure 5B ) (treatment 6 time interaction F(3,21)=0.75, P=0.77).
Eect of exogenous i.v. CCK-8 on vagal eerent activity in animals with total subdiaphragmatic vagotomy after i.c.m. pretreatment with CCK A receptor antagonist
The vagal eerent activity response to 0.1 nmol CCK-8 was studied at dierent time intervals after the i.c.m. injection of CCK A receptor antagonist (1 mg) in animals with total subdiaphragmatic vagotomy. The reproducibility of the response of the vagal eerent activity to injections of CCK-8 at 10 min intervals was con®rmed in control experiments. Ten to twenty minutes after the application of CCK A receptor antagonist the response of vagal eerent activity to CCK-8 was completely blocked (treatment 6 time interaction F(1,7)=3.04, P=0.007), (Figure 6 ). The response of i.v. CCK-8 returned after 40 ± 50 min after i.c.m. injection of CCK A receptor antagonist (data not shown).
Eect of exogenous i.v. CCK-8 on the aerent activity of supradiaphragmatic vagal nerves
In order to elucidate the contribution of supradiaphragmatic vagal aerents in the response of vagal gastric eerent activity to CCK-8, the response of vagal aerents at the cervical level was recorded after total subdiaphragmatic vagotomy ( Figure  7) . No signi®cant eect of 1.0 nmol CCK-8 was found when compared to the saline treated group.
Discussion
The results show that administration of exogenous 0.1 ± 1.0 nmol CCK-8 (ca 0.35 ± 3.5 mg kg 71 ) signi®cantly decreased the gastric vagal eerent nerve activity. This eect of CCK-8 on gastric vagal eerent activity was mediated by CCK A receptors, localized both peripherally and centrally.
In the present study exogenous CCK-8 induced a decrease of gastric vagal eerent activity and this eect of CCK-8 was signi®cantly diminished after total subdiaphragmatic vagotomy, suggesting that the main site of action of CCK-8 was the subdiaphragmatic vagal aerents. These results are supported by Schwartz et al. (1994) and Kurosawa et al. (1997) who have demonstrated that intravenous injection of CCK-8 increases the vagal gastric aerent activity dose-dependently. The present vago-vagal neural mechanism underlies the re¯ex responses to CCK-8 of the gastric motility and emptying (Raybould & TacheÂ , 1988; Grundy et al., 1995; Rogers et al., The ®nding that CCK-8 still had an eect on eerent activity after total subdiaphragmatic vagotomy suggests that CCK-8 also might stimulate supradiaphragmatic vagal aerents, and/or act directly on central vagal sites. We had excluded the involvement of supradiaphragmatic vagal aerents in the response of gastric vagal eerents to exogenous CCK-8, since intravenous injection of 1 nmol of CCK-8, a dose signi®cantly aecting both subdiaphragmatic vagal aerent and eerent activity, had no eect on the activity of supradiaphragmatic vagal aerents. Although it is generally accepted that CCK does not readily cross the blood-brain barrier in the time course of the current experiments (Oldendorf, 1981) , recent studies suggest that CCK and related peptides may have access to speci®c brain sites where the blood-brain barrier is incomplete (Harro et al., 1993; Hagino & Moroji, 1994) . In addition, larger doses of CCK-8 (4 ± 16 mg kg
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) may activate non-vagal sympathetic aerents as reduction in food intake has been observed in rats with subdiaphragmatic vagal deaerentation (Moran et al., 1997) .
CCK-8 exerts its physiological eects via either CCK A or CCK B receptors. Studies by Schwartz et al. (1994) and Kurosawa et al. (1997) demonstrated that the gastric vagal aerents are activated via CCK A receptors, indicating that the profound decrease in the gastric vagal eerent activity in animals with partial subdiaphragmatic vagotomy is mainly produced via stimulation of the CCK A receptors located on the vagal aerent terminals (Zarbin et al., 1981) .
In order to further determine the type of CCK receptors involved in the inhibition of gastric vagal eerent nerve activity and the localization of the receptors being activated in rats with total subdiaphragmatic vagotomy, CCK A (i.v. or i.c.m.) or CCK B (i.v.) receptor antagonist were injected prior to the administration of CCK-8. Systemically administered L-364,718 and L-365,260 have been shown to be able to cross the blood-brain barrier and to reduce the central responses of peripherally administered CCK-8 and CCK-8-related peptides (Hagino & Moroji, 1994; Ladurelle et al., 1997; Lin & Lin, 1990) . However, this occurs slowly and is unlikely to account for the eects observed in current experiments. Intravenous injection of a CCK A receptor antagonist blocked the response of vagal eerent activity while that of a CCK B receptor antagonist had no eect on the response, indicating that the eect of CCK-8 on vagal eerent activity after total vagotomy was mediated through CCK A , but not CCK B receptors. Moreover, i.c.m. administration of 1 mg of the CCK A receptor antagonist, a dose which showed a partial block when administered intravenously, completely blocked the response of the vagal eerent activity to peripherally administered CCK-8. These results suggest that the response of the vagal eerent activity to CCK-8 in rats with total subdiaphragmatic vagotomy are mainly mediated via the centrally located CCK A receptors (Branchereau et al., 1993) , possibly those in area postrema etc. where the blood-brain barrier is lacking (Gross et al., 1990; MoÈ nnikes et al., 1997; Moran et al., 1986) . In accordance with our ®ndings, it has been shown (MoÈ nnikes et al., 1997) that the activation of some of the nuclei in the brain such as the paraventricular nucleus, NTS and especially the area postrema by systemic administration of CCK-8 was not totally dependent on the vagal aerent excitation, suggesting the contribution of central CCK receptors. The central CCK A receptor would further augment the responses of the vagal eerent nerve activity in animals with intact vagal aerents (Barber et al., 1995) .
Conclusion
The eect of exogenous CCK-8 on vagal eerent activity was realized mainly through peripheral CCK A receptors located on the subdiaphragmatic vagal aerents, but not through CCK B . The response of the eerent activity can be partly mediated through the central CCK A receptors. Our present results are in line with earlier studies showing that CCK A receptors play a major role in regulating the aerent and eerent gastric vagal activity in response to CCK-8. These neural mechanisms underlie the involvement of CCK-8 in the re¯ex regulation of gastric motility, emptying, and acid secretion.
